01—Abstract
Summary
Summary of the 8-K filed November 3, 2025. Cited figures are marked; the original filing is the authoritative source.
On November 1, 2025, DuPont de Nemours, Inc. completed the separation of its Electronics business, Qnity Electronics, Inc., into an independent public company through a pro rata dividend in-kind of Qnity common stock to DuPont shareholders.
DuPont has no ownership interest in Qnity following the Effective Time. Qnity common stock began "regular way" trading on the NYSE under the symbol "Q" on November 3, 2025, and DuPont continues to trade under "DD." Shareholders of record as of October 22, 2025 received one Qnity share for every two DuPont shares held, with cash paid in lieu of fractional shares. The companies entered into a set of separation agreements effective November 1, 2025, including a Separation and Distribution Agreement, Tax Matters Agreement, Employee Matters Agreement, Intellectual Property Cross-License Agreement, Transition Services Agreements, and a Legacy Liabilities Assignment Agreement, under which Qnity is allocated its applicable percentage of certain legacy liabilities and funding obligations and will indemnify DuPont for them.
Leadership changed as well. Directors Terrence R. Curtin, Kristina M.
Johnson and Steven M. Sterin resigned, and the board was reduced from thirteen to ten members. Edward D.
Breen stepped down as Executive Chairman but remains Chairman in a non-executive role. Jon D. Kemp (President of Electronics) and Michael Goss (Vice President and Controller) resigned, and Jeroen Bloemhard, Beth Ferreira and Madeleine Barber were appointed to the roles of President of Healthcare & Water Technologies, President of Diversified Industrials, and Vice President of Tax, Controller and Chief Accounting Officer, respectively.
On the capital structure side, DuPont's special mandatory redemption provisions were triggered under the New Notes issued in its exchange offers, requiring redemption of $900,000,000a of New 2028 Notes, $225,963,000 of New 2038 Notes and $294,781,000 of New 2048 Notes, with holder notice due by November 17, 2025. DuPont also entered a transaction support agreement with holders of 83.90% of the 2038 Notes and 60.25% of the 2048 Notes to support consent solicitations for proposed indenture amendments permitting the separation and the proposed sale of its aramids business, and a tender offer for up to $739,256,000 of 2048 Notes at $1,000 per $1,000 principal amount. The company expects to have repaid approximately $4.0 billion of senior notes, with total refinancing expenses of approximately $168 million.
02—Key points
Key Highlights
- Completed the separation of the Electronics business into Qnity Electronics, Inc. effective November 1, 2025; DuPont holds no ownership interest in Qnity afterward.
- Qnity common stock began regular way trading on the NYSE under "Q" on November 3, 2025; DuPont continues to trade under "DD."
- Shareholders received one Qnity share for every two DuPont shares held as of October 22, 2025, with cash in lieu of fractional shares; approximately 209 million Qnity shares were distributed.
- Legacy Liabilities Assignment Agreement allocates the applicable percentage of certain legacy liabilities and Memorandum of Understanding funding obligations to Qnity, which will indemnify DuPont; DuPont's Minimum EBITDA under the Corteva Letter Agreement is now $2.5 billion multiplied by its Applicable DuPont Percentage, to be disclosed later.
- Board reduced from thirteen to ten members after three directors resigned; Edward D. Breen moved from Executive Chairman to non-executive Chairman.
- Special mandatory redemption triggered on New Notes: $900 million of New 2028 Notes, $225.963 million of New 2038 Notes and $294.781 million of New 2048 Notes must be redeemed, with notices due by November 17, 2025.
- Transaction Support Agreement with holders of 83.90% of the 2038 Notes and 60.25% of the 2048 Notes; tender offer for up to $739.256 million of 2048 Notes at $1,000 per $1,000 principal, with expected repayment of about $4.0 billion of senior notes and refinancing expenses of about $168 million.
03—Questions
Frequently Asked Questions
How did DuPont shareholders receive their Qnity shares, and what happens to fractional shares?
Holders of record as of the close of business on October 22, 2025 received one share of Qnity common stock for every two shares of DuPont common stock held through a pro rata dividend in-kind. No fractional shares were issued; shareholders receive cash in lieu of fractional shares.
Does DuPont still own any part of Qnity Electronics?
No. As of the Effective Time on November 1, 2025, Qnity became an independent, publicly traded company, and the filing states that DuPont has no ownership interest in Qnity.
Who is leaving and joining DuPont's leadership and board?
Directors Terrence R. Curtin, Kristina M. Johnson and Steven M. Sterin resigned, reducing the board from thirteen to ten members. Jon D. Kemp (President of Electronics) and Michael Goss (Vice President and Controller) resigned. Jeroen Bloemhard, Beth Ferreira and Madeleine Barber were appointed as President of Healthcare & Water Technologies, President of Diversified Industrials, and Vice President of Tax, Controller and Chief Accounting Officer, respectively. Edward D. Breen resigned as Executive Chairman and remains Chairman in a non-executive capacity.
What debt actions is DuPont taking after the separation?
DuPont must redeem $900,000,000 of New 2028 Notes, $225,963,000 of New 2038 Notes and $294,781,000 of New 2048 Notes under special mandatory redemption provisions, with holder notice due by November 17, 2025. It also launched consent solicitations for the 2038 and 2048 Notes and a tender offer for up to $739,256,000 of 2048 Notes at $1,000 per $1,000 principal amount, expiring December 3, 2025 unless extended. The company expects to repay approximately $4.0 billion of senior notes, with total refinancing expenses of approximately $168 million, and no longer expects to redeem 2028 Notes beyond the special mandatory redemption amount.
What financial obligations did Qnity take on from DuPont?
Under the Legacy Liabilities Assignment Agreement, Qnity was allocated the Applicable ElectronicsCo Percentage of certain Legacy Liabilities under the Corteva Letter Agreement and of DuPont's funding obligations under the January 22, 2021 Memorandum of Understanding, including escrow funding. Qnity will indemnify DuPont for these amounts. The filing does not state specific dollar amounts for these allocations.
04—Continue